Innovative financing into hepatitis B and C prevention and treatment in low and middle income countries.
Geneva: IFPMA; 2016. 2,8 MB ( .pdf).
VHPB launches report on Innovative Financing into Hep B and C Prevention and Treatment.
Read the blog:
The presentations of the VHPB meeting in Ljublana on 10 and 11 March 2016 on: 'Highlight underserved for screening, prevention and treatment of viral hepatitis B and C in Europe' are online.
Centre for Evaluation of Vaccination (CEV)Vaccine & Infectious Disease Institute (Vaxinfectio)
University of Antwerp
B-2610 Antwerp, Belgium
Tel: +32(0)3 265 25 23
Fax: +32(0)3 265 26 40
Executive SecretaryPierre Van Damme
Administrative and Scientific SecretariatBrenda Janssens | Greet HendrickxAlex Vorsters | Xenia Mikulla | Sara Valckx
Follow us on
Subscribe here for the VHPB e-mail service
This website is part of the WHO vaccine safety net
Last review cycle June 2020open pdf documents